国际简称:RATION PHARMACOTHER 参考译名:心脏病学的合理药物治疗
主要研究方向:CARDIAC & CARDIOVASCULAR SYSTEMS 非预警期刊 审稿周期: 6 Weeks
《心脏病学的合理药物治疗》(Rational Pharmacotherapy In Cardiology)是一本由Stolichnaya Izdatelskaya Kompaniya出版的以CARDIAC & CARDIOVASCULAR SYSTEMS为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊,近三年没有被列入预警名单。
Rational Pharmacology in Cardiology is a professional academic journal dedicated to drug therapy and prevention in the field of cardiovascular disease. Its aim is to gather the latest research achievements in drug therapy for cardiovascular disease and provide a communication platform for clinical doctors and researchers engaged in cardiovascular disease treatment and prevention. Committed to promoting scientific progress and clinical practice in the field of cardiovascular disease treatment through high-quality research papers, review articles, case reports, and review articles. In addition, it also focuses on the rationality and effectiveness of drug use in clinical practice to help clinicians make more informed treatment decisions.
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||
1 | 0.17 | 0.281 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | 203 / 220 |
8% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS | ESCI | Q4 | 205 / 220 |
7.05% |